Advertisement

The Latest

Webinars Separating AI Hype from Impact: Repeatable Outcomes and ROI When AI Understands Full Patient Complexity

Join Dr. Kalie Dove-Maguire, President and Chief Product Officer at Evidently, and physician leaders from major health systems for a direct conversation about what repeatable clinical AI outcomes look like when clinicians finally have the full complexity of the patient…

Sep 8, 2026 12:00 PM - 1:00 PM CDT

Presented by:

Presented by
Presenters:
  • Kalie Dove-Maguire, MD, President and Chief Product Officer, Evidently
  • David Marcozzi, MD, MHS-CL, FACEP, Chief Clinical Officer and Senior Vice President, University of Maryland Medical Center
  • James M. Blum, MD, CDH-E, Chief Health Information Officer, University of Iowa
  • Spencer Dorn MD, MPH, MHA, Executive Medical Director, University of North Carolina at Chapel Hill

New York cardiology office to reopen after May fire

After a fire in late May temporarily closed Highland Cardiology at Red Creek in Rochester, N.Y., the cardiology office is set to reopen on Aug. 3.  During the closure, only a handful of appointments were rescheduled, according to a spokesperson…

By: Paige Twenter

When payers automate denial, clinicians must automate defense

The American Medical Association has flagged what frontline physicians already feel: AI is being deployed faster on the denial side of healthcare than on the care side. Prior-authorization denials are rising, and increasingly the first “reviewer” of a surgeon’s request…

Zain Khalpey, MD, PhD

Virginia Cardiovascular Specialists debuts expanded clinic, cardiac PET imaging

Virginia Cardiovascular Specialists has opened an expanded 12,000-square-foot clinic at Bell Creek Medical Park in Mechanicsville, Va., adding cardiac positron emission tomography imaging to the location for the first time, according to a news release shared with Becker’s. The facility…

By: Brad Lewis

Novo Nordisk cardiovascular disease drug flunks phase 3 trial

Novo Nordisk said July 31 that its experimental medication, ziltivekimab, failed to reduce major adverse cardiovascular events in a phase 3 trial.  The monthly medication, 15 milligrams of ziltivekimab, was part of a double-blind study with more than 6,300 participants…

By: Paige Twenter

Webinars How dental and DSO leaders are moving beyond AI pilots to drive real behavior change

Most AI implementations don’t fail because of the technology. They fail because organizations focus on deployment instead of behavior change. Clinicians don’t resist innovation — they resist disruption that doesn’t clearly improve patient care or make their day easier. Featuring…

On Demand

Presented by:

Presented by
Presenters:
  • Matthew Brown, DSO Partnerships, Dandy
  • Dr. Layla Lohmann, Co-Founder and Clinical Director, Apex Dental Partners

Whitepapers Why arrival by EMS can be a more complex ED visit than the record shows

EMS clinicians routinely identify and treat patients with conditions like hypoxia, hypotension, shock or sepsis before reaching the emergency department. By the time an emergency physician evaluates the patient, the initial instability may have resolved but clinical complexity, monitoring needs…

Presented by:

Presented by

Whitepapers Build a DSO revenue cycle that scales with your growth

DSO affiliation among U.S. dentists more than doubled over the past decade, rising from 7.2% in 2015 to 16.1% in 2024. That growth creates opportunity, but it also raises the operational stakes. A revenue cycle that works cleanly across two…

Presented by:

Presented by
Advertisement